|
PCMT1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.137200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.463200E-01 |
| Normal-vs-Stage2 |
5.966600E-01 |
| Normal-vs-Stage3 |
1.528630E-01 |
| Normal-vs-Stage4 |
1.118580E-01 |
| Stage1-vs-Stage2 |
7.811800E-01 |
| Stage1-vs-Stage3 |
2.319800E-01 |
| Stage1-vs-Stage4 |
1.592610E-01 |
| Stage2-vs-Stage3 |
5.884200E-01 |
| Stage2-vs-Stage4 |
4.070200E-01 |
| Stage3-vs-Stage4 |
6.241000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.952600E-01 |
| Normal-vs-AfricanAmerican |
8.102000E-01 |
| Normal-vs-Asian |
7.839400E-01 |
| Caucasian-vs-AfricanAmerican |
7.242400E-01 |
| Caucasian-vs-Asian |
6.422200E-01 |
| AfricanAmerican-vs-Asian |
9.969400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.034350E-01 |
| Normal-vs-Female |
5.474600E-01 |
| Male-vs-Female |
1.410400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.948400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.951800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.765240E-01 |
| Normal-vs-Age(81-100Yrs) |
3.777600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.795200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.844600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.846400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.073400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.975200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.413200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.678800E-01 |
| Classical-VS-Follicular |
5.463400E-01 |
| Classical-VS-Other |
2.081400E-01 |
| Classical-VS-Normal |
5.930600E-01 |
| Tall-VS-Follicular |
6.661400E-01 |
| Tall-VS-Other |
2.210200E-01 |
| Tall-VS-Normal |
6.850600E-01 |
| Follicular-VS-Other |
5.027600E-01 |
| Follicular-VS-Normal |
3.827000E-01 |
| Other-VS-Normal |
2.827000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.867400E-01 |
| Normal-vs-N1 |
6.135500E-03 |
| N0-vs-N1 |
1.745710E-02 |
|
|
